Table 2 Clinical and biological characteristics

Number

68

53

Average age/years, (Mean ± SD)

40.2 ± 16.2

34.1 ± 13.6

0.07

Female, n (%)

13 (19.1%)

26 (49.1%)

< 0.01

History of Perianal involvement, n (%)

15 (22.1%)

15 (28.3%)

0.43

History of surgery, n (%)

20 (33.3%)

15 (32.4%)

0.89

Inflammatory biomarkers, n (%)

 ESR (> 7.2 mm/L)

13 (19.1%)

18 (34.0%)

0.09

 CRP (> 8 mg/L)

14 (20.6%)

21 (39.6%)

0.02

Treatment measures, n (%)

0.22

 Anti-TNF antibodies

32 (47.1%)

17 (32.1%)

 Immunosuppressant

18 (26.5%)

14 (26.4%)

 Hormone steroid

1 (1.5%)

3 (5.7%)

 Combination of two or more drugs

17 (25.0%)

19 (35.8%)

tCDEIS(IQR, Center1)

10,00 (2.50)

3.50 (1.50)

–

tCDEIS(IQR, Center2)

9.50 (2.00)

3.25 (2.00)

–